Hematology/Oncology News

Professional fulfillment can be achieved through a culture of wellness, efficiency of practice in the workplace and personal resilience, according to a speaker at the Ending Clinician Burnout Global Summit.

On this special edition episode, Hansa Bhargava, MD, with Oncology Overdrive’s Shikha Jain, MD, and Mend the Gap’s Dagny Zhu, MD, discuss physician burnout and managing a good work-life balance with a panel of guests.

Patients who received chimeric antigen receptor T-cell therapy did not exhibit increased risk for second primary malignancies compared with those who received other standard treatments, according to a systematic review and meta-analysis.

Ann H. Partridge, MD, MPH, will receive this year’s ESMO Award.

Girls with diagnosed mental health conditions had lower HPV vaccination coverage than their peers without mental health conditions, according to a study published in The Lancet Public Health.

Modified FOLFIRINOX induction chemotherapy prior to standard chemoradiation, surgery and adjuvant chemotherapy improved outcomes for patients with locally advanced rectal cancer, according to a long-term analysis of a randomized phase 3 trial.

The Inflation Reduction Act’s cap on out-of-pocket spending saved patients with cancer more than $7,000 a year on oral chemotherapy medications, a research letter analysis published in JAMA Network Open showed.

In this video interview, Sara M. Tolaney, MD, MPH, discusses the individualized sequential therapies provided to patients based on the breast cancer subtype, genomics and other factors.

In this video interview, Sara M. Tolaney, MD, MPH, highlights the increasing incidence in breast cancer.

In this video interview, Sara M. Tolaney, MD, MPH, discusses the approvals of antibody-drug conjugates and oral targeted agents that improve outcomes among patients with breast cancer.